Alirocumab – new bad cholesterol-reducing drug to hit the market soon

January 12, 2015 5:03 AM

4 0

Alirocumab, a new and experimental drug from Sanofi SA and Regeneron Pharmaceuticals is set to hit the market soon after it proved highly effective at reducing bad cholesterols in the body, and lowering the heart risks of patients by as much as 50%.

Alirocumab is an injectable drug, and its effectiveness has been proven beyond doubts after it was administered once every four weeks with impressive results, instead of the usual dose of once every two weeks for some other related drugs. Alirocumab works by blocking PCSK9 – a protein that naturally...

Read more

To category page

Loading...